Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Equity-informative economic analysis of financial protection in Canadian pharmacare programs

EF 2022-23

Résumé
Government-funded prescription drug insurance (pharmacare) programs aim to improve access to healthcare by protecting people from the financial hardship of drug costs. However, current gaps in drug insurance are difficult for patients: lack of coverage is associated with not being able to take medications because of cost and unfair differences in the use of health services and medications. Accordingly, equity in drug insurance coverage among the people who need it is an important health system goal. This is also a motivation for plans to establish a national pharmacare program in Canada. Although a national program is under development, some Canadian provinces already provide partial coverage. For example, British Columbia implemented a program in 2003 to cover a broad range of medications for low-income households. Despite its value to patients and health systems, little is known about the equity of financial protection in Canada and other wealthy countries. Past research has shown that financial protection can influence health through multiple pathways that are important for equity. Factors such as age, sex and gender, geography and ethnicity are critical for understanding how financial protection is divided among people who need it and its health implications. With drug costs rising for patients and insurers, my research aims to guide decisions about how pharmacare programs can improve the equity of protection from financial hardships. To achieve this, I will identify factors and measures used to evaluate the equity of protection from financial hardships; study the effects of British Columbia's pharmacare program on the distribution of financial protection according to factors that are important for equity; and assess how financial protection would be distributed to those who need it by different ways of implementing national pharmacare in Canada. Results from my research will help policy-makers to improve the fairness of pharmacare programs.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
475578
Name
Xie Edward
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Equity-informative economic analysis of financial protection in Canadian pharmacare programs
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Canadian Health Policy; Determinants Of Health; Economic Evaluation; Health Equity; Health Services Financing; Health Services Research; Pharmaceuticals; Statistical Analysis
Abstract
Government-funded prescription drug insurance (pharmacare) programs aim to improve access to healthcare by protecting people from the financial hardship of drug costs. However, current gaps in drug insurance are difficult for patients: lack of coverage is associated with not being able to take medications because of cost and unfair differences in the use of health services and medications. Accordingly, equity in drug insurance coverage among the people who need it is an important health system goal. This is also a motivation for plans to establish a national pharmacare program in Canada. Although a national program is under development, some Canadian provinces already provide partial coverage. For example, British Columbia implemented a program in 2003 to cover a broad range of medications for low-income households. Despite its value to patients and health systems, little is known about the equity of financial protection in Canada and other wealthy countries. Past research has shown that financial protection can influence health through multiple pathways that are important for equity. Factors such as age, sex and gender, geography and ethnicity are critical for understanding how financial protection is divided among people who need it and its health implications. With drug costs rising for patients and insurers, my research aims to guide decisions about how pharmacare programs can improve the equity of protection from financial hardships. To achieve this, I will identify factors and measures used to evaluate the equity of protection from financial hardships; study the effects of British Columbia's pharmacare program on the distribution of financial protection according to factors that are important for equity; and assess how financial protection would be distributed to those who need it by different ways of implementing national pharmacare in Canada. Results from my research will help policy-makers to improve the fairness of pharmacare programs.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Xie, Edward
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~